Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 241

1.

Lipoprotein(a) plasma levels are not associated with incident microvascular complications in type 2 diabetes mellitus.

Singh SS, Rashid M, Lieverse AG, Kronenberg F, Lamina C, Mulder MT, de Rijke YB, Sijbrands EJG, van Hoek M.

Diabetologia. 2020 Mar 9. doi: 10.1007/s00125-020-05120-9. [Epub ahead of print]

PMID:
32152647
2.

High prevalence of impaired awareness of hypoglycemia and severe hypoglycemia among people with insulin-treated type 2 diabetes: The Dutch Diabetes Pearl Cohort.

van Meijel LA, de Vegt F, Abbink EJ, Rutters F, Schram MT, van der Klauw MM, Wolffenbuttel BHR, Siegelaar S, DeVries JH, Sijbrands EJG, Özcan B, de Valk HW, Silvius B, Schaper N, Stehouwer CDA, Elders PJM, Tack CJ, de Galan BE.

BMJ Open Diabetes Res Care. 2020 Feb;8(1). pii: e000935. doi: 10.1136/bmjdrc-2019-000935.

3.

Sex difference in the incidence of microvascular complications in patients with type 2 diabetes mellitus: a prospective cohort study.

Singh SS, Roeters-van Lennep JE, Lemmers RFH, van Herpt TTW, Lieverse AG, Sijbrands EJG, van Hoek M.

Acta Diabetol. 2020 Feb 5. doi: 10.1007/s00592-020-01489-6. [Epub ahead of print]

PMID:
32025877
4.

Optimizing Clinical Cardiovascular Outcomes by a Personalized Approach to Add Ezetimibe to a Statin.

Weingärtner O, Sijbrands EJG, Lütjohann D.

J Am Coll Cardiol. 2020 Jan 7;75(1):128. doi: 10.1016/j.jacc.2019.08.1072. No abstract available.

PMID:
31918825
5.

Interpreting the Benefit of Simvastatin-Ezetimibe in Patients 75 Years or Older.

Weingärtner O, Sijbrands EJG, Lütjohann D.

JAMA Cardiol. 2020 Jan 2. doi: 10.1001/jamacardio.2019.5197. [Epub ahead of print] No abstract available.

PMID:
31895451
6.

The effect of guideline revisions on vascular complications of type 2 diabetes.

Heijmans R, Singh SS, Lieverse AG, Sijbrands EJG, van Hoek M.

Ther Adv Endocrinol Metab. 2019 Sep 27;10:2042018819875408. doi: 10.1177/2042018819875408. eCollection 2019.

7.

Dietary antioxidant capacity and risk of type 2 diabetes mellitus, prediabetes and insulin resistance: the Rotterdam Study.

van der Schaft N, Schoufour JD, Nano J, Kiefte-de Jong JC, Muka T, Sijbrands EJG, Ikram MA, Franco OH, Voortman T.

Eur J Epidemiol. 2019 Sep;34(9):853-861. doi: 10.1007/s10654-019-00548-9. Epub 2019 Aug 9.

8.

An integrative cross-omics analysis of DNA methylation sites of glucose and insulin homeostasis.

Liu J, Carnero-Montoro E, van Dongen J, Lent S, Nedeljkovic I, Ligthart S, Tsai PC, Martin TC, Mandaviya PR, Jansen R, Peters MJ, Duijts L, Jaddoe VWV, Tiemeier H, Felix JF, Willemsen G, de Geus EJC, Chu AY, Levy D, Hwang SJ, Bressler J, Gondalia R, Salfati EL, Herder C, Hidalgo BA, Tanaka T, Moore AZ, Lemaitre RN, Jhun MA, Smith JA, Sotoodehnia N, Bandinelli S, Ferrucci L, Arnett DK, Grallert H, Assimes TL, Hou L, Baccarelli A, Whitsel EA, van Dijk KW, Amin N, Uitterlinden AG, Sijbrands EJG, Franco OH, Dehghan A, Spector TD, Dupuis J, Hivert MF, Rotter JI, Meigs JB, Pankow JS, van Meurs JBJ, Isaacs A, Boomsma DI, Bell JT, Demirkan A, van Duijn CM.

Nat Commun. 2019 Jun 13;10(1):2581. doi: 10.1038/s41467-019-10487-4.

9.

Novel metabolic indices and incident type 2 diabetes among women and men: the Rotterdam Study.

Brahimaj A, Rivadeneira F, Muka T, Sijbrands EJG, Franco OH, Dehghan A, Kavousi M.

Diabetologia. 2019 Sep;62(9):1581-1590. doi: 10.1007/s00125-019-4921-2. Epub 2019 Jun 10.

10.

Predictors and patterns of eating behaviors across childhood: Results from The Generation R study.

Derks IPM, Bolhuis K, Sijbrands EJG, Gaillard R, Hillegers MHJ, Jansen PW.

Appetite. 2019 Oct 1;141:104295. doi: 10.1016/j.appet.2019.05.026. Epub 2019 May 22.

PMID:
31128200
11.

Mortality Risk Associated With Truncating Founder Mutations in Titin.

Jansen M, Baas AF, van Spaendonck-Zwarts KY, Ummels AS, van den Wijngaard A, Jongbloed JDH, van Slegtenhorst MA, Lekanne Deprez RH, Wessels MW, Michels M, Houweling AC, Hoorntje ET, Helderman-van den Enden PJTM, Barge-Schaapveld DQCM, Peter van Tintelen J, van den Berg MP, Wilde AAM, Ploos van Amstel HK, Hennekam EAM, Asselbergs FW, Sijbrands EJG, Dooijes D.

Circ Genom Precis Med. 2019 May;12(5):e002436. doi: 10.1161/CIRCGEN.118.002436.

PMID:
31112426
12.

The emerging concept of "individualized cholesterol-lowering therapy": A change in paradigm.

Lütjohann D, Stellaard F, Mulder MT, Sijbrands EJG, Weingärtner O.

Pharmacol Ther. 2019 Jul;199:111-116. doi: 10.1016/j.pharmthera.2019.03.004. Epub 2019 Mar 12. Review.

PMID:
30877023
13.

Challenges and Opportunities for Cancer Predisposition Cascade Screening for Hereditary Breast and Ovarian Cancer and Lynch Syndrome in Switzerland: Findings from an International Workshop.

Nikolaidis C, Ming C, Pedrazzani C, van der Horst T, Kaiser-Grolimund A, Ademi Z, Bührer-Landolt R, Bürki N, Caiata-Zufferey M, Champion V, Chappuis PO, Kohler C, Erlanger TE, Graffeo R, Hampel H, Heinimann K, Heinzelmann-Schwarz V, Kurzeder C, Monnerat C, Northouse LL, Pagani O, Probst-Hensch N, Rabaglio M, Schoenau E, Sijbrands EJG, Taborelli M, Urech C, Viassolo V, Wieser S, Katapodi MC; for the CASCADE Consortium.

Public Health Genomics. 2018;21(3-4):121-132. doi: 10.1159/000496495. Epub 2019 Jan 29.

PMID:
30695780
14.

ClinVar database of global familial hypercholesterolemia-associated DNA variants.

Iacocca MA, Chora JR, Carrié A, Freiberger T, Leigh SE, Defesche JC, Kurtz CL, DiStefano MT, Santos RD, Humphries SE, Mata P, Jannes CE, Hooper AJ, Wilemon KA, Benlian P, O'Connor R, Garcia J, Wand H, Tichy L, Sijbrands EJ, Hegele RA, Bourbon M, Knowles JW; ClinGen FH Variant Curation Expert Panel.

Hum Mutat. 2018 Nov;39(11):1631-1640. doi: 10.1002/humu.23634.

15.

Eating behavior and body composition across childhood: a prospective cohort study.

Derks IPM, Sijbrands EJG, Wake M, Qureshi F, van der Ende J, Hillegers MHJ, Jaddoe VWV, Tiemeier H, Jansen PW.

Int J Behav Nutr Phys Act. 2018 Oct 1;15(1):96. doi: 10.1186/s12966-018-0725-x.

16.

Plasma protein N-glycan signatures of type 2 diabetes.

Dotz V, Lemmers RFH, Reiding KR, Hipgrave Ederveen AL, Lieverse AG, Mulder MT, Sijbrands EJG, Wuhrer M, van Hoek M.

Biochim Biophys Acta Gen Subj. 2018 Dec;1862(12):2613-2622. doi: 10.1016/j.bbagen.2018.08.005. Epub 2018 Aug 6.

PMID:
30251656
17.

Clinical Genetic Testing for Familial Hypercholesterolemia: JACC Scientific Expert Panel.

Sturm AC, Knowles JW, Gidding SS, Ahmad ZS, Ahmed CD, Ballantyne CM, Baum SJ, Bourbon M, Carrié A, Cuchel M, de Ferranti SD, Defesche JC, Freiberger T, Hershberger RE, Hovingh GK, Karayan L, Kastelein JJP, Kindt I, Lane SR, Leigh SE, Linton MF, Mata P, Neal WA, Nordestgaard BG, Santos RD, Harada-Shiba M, Sijbrands EJ, Stitziel NO, Yamashita S, Wilemon KA, Ledbetter DH, Rader DJ; Convened by the Familial Hypercholesterolemia Foundation.

J Am Coll Cardiol. 2018 Aug 7;72(6):662-680. doi: 10.1016/j.jacc.2018.05.044. Review.

18.

Use of monomeric and oligomeric flavanols in the dietary management of patients with type 2 diabetes mellitus and microalbuminuria (FLAVA trial): study protocol for a randomized controlled trial.

Rashid M, Verhoeven AJM, Mulder MT, Timman R, van Beek-Nieuwland Y, Athumani AA, Zandbergen AAM, van der Wiel HE, Sijbrands EJG, Berk KA.

Trials. 2018 Jul 16;19(1):379. doi: 10.1186/s13063-018-2762-9.

19.

High Diabetes Distress Among Ethnic Minorities Is Not Explained by Metabolic, Cardiovascular, or Lifestyle Factors: Findings From the Dutch Diabetes Pearl Cohort.

Özcan B, Rutters F, Snoek FJ, Roosendaal M, Sijbrands EJ, Elders PJM, Holleman F, Pijl H, Tack CJ, Abbink EJ, de Valk HW, Wolffenbuttel BHR, Stehouwer CDA, Schaper NC, Dekker JM, Schram MT; Diabetes Pearl from the Parelsnoer Initiative.

Diabetes Care. 2018 Sep;41(9):1854-1861. doi: 10.2337/dc17-2181. Epub 2018 Jun 26.

PMID:
29945936
20.

Transcription factor 7-like 2 gene links increased in vivo insulin synthesis to type 2 diabetes.

Jainandunsing S, Koole HR, van Miert JNI, Rietveld T, Wattimena JLD, Sijbrands EJG, de Rooij FWM.

EBioMedicine. 2018 Apr;30:295-302. doi: 10.1016/j.ebiom.2018.03.026. Epub 2018 Mar 30.

21.

Cardiovascular risk in patients with familial hypercholesterolemia using optimal lipid-lowering therapy.

Galema-Boers AM, Lenzen MJ, Engelkes SR, Sijbrands EJ, Roeters van Lennep JE.

J Clin Lipidol. 2018 Mar - Apr;12(2):409-416. doi: 10.1016/j.jacl.2017.12.014. Epub 2018 Jan 2.

PMID:
29398430
22.

Group cognitive behavioural therapy and weight regain after diet in type 2 diabetes: results from the randomised controlled POWER trial.

Berk KA, Buijks HIM, Verhoeven AJM, Mulder MT, Özcan B, van 't Spijker A, Timman R, Busschbach JJ, Sijbrands EJ.

Diabetologia. 2018 Apr;61(4):790-799. doi: 10.1007/s00125-017-4531-9. Epub 2018 Jan 9.

23.

Testing the direction of effects between child body composition and restrictive feeding practices: results from a population-based cohort.

Derks IP, Tiemeier H, Sijbrands EJ, Nicholson JM, Voortman T, Verhulst FC, Jaddoe VW, Jansen PW.

Am J Clin Nutr. 2017 Sep;106(3):783-790. doi: 10.3945/ajcn.117.156448. Epub 2017 Aug 9.

PMID:
28793987
24.

Individual and partner's level of occupation and the association with HbA1c levels in people with Type 2 diabetes mellitus: the Dutch Diabetes Pearl cohort.

Rutte A, Rauh SP, Schram MT, Nijpels G, DeVries JH, Holleman F, Pijl H, Dekkers OM, Özcan B, Sijbrands EJG, Tack CJ, Abbink EJ, de Valk HW, Silvius B, Wolffenbuttel BHR, Stehouwer CDA, Schaper NC, Dekker JM, Beulens JW, Elders PJM, Rutters F; Diabetes Pearl from the Parelsnoer Initiative.

Diabet Med. 2017 Nov;34(11):1623-1628. doi: 10.1111/dme.13422. Epub 2017 Aug 3.

PMID:
28703888
25.

IgG glycan patterns are associated with type 2 diabetes in independent European populations.

Lemmers RFH, Vilaj M, Urda D, Agakov F, Šimurina M, Klaric L, Rudan I, Campbell H, Hayward C, Wilson JF, Lieverse AG, Gornik O, Sijbrands EJG, Lauc G, van Hoek M.

Biochim Biophys Acta Gen Subj. 2017 Sep;1861(9):2240-2249. doi: 10.1016/j.bbagen.2017.06.020. Epub 2017 Jun 28.

26.

Introduction of the DiaGene study: clinical characteristics, pathophysiology and determinants of vascular complications of type 2 diabetes.

van Herpt TTW, Lemmers RFH, van Hoek M, Langendonk JG, Erdtsieck RJ, Bravenboer B, Lucas A, Mulder MT, Haak HR, Lieverse AG, Sijbrands EJG.

Diabetol Metab Syndr. 2017 Jun 19;9:47. doi: 10.1186/s13098-017-0245-x. eCollection 2017.

27.

Soluble LR11 associates with aortic root calcification in asymptomatic treated male patients with familial hypercholesterolemia.

Vongpromek R, Bos S, Ten Kate GR, Bujo H, Jiang M, Nieman K, Schneider W, Roeters van Lennep JE, Verhoeven AJM, Sijbrands EJG, Mulder MT.

Atherosclerosis. 2017 Oct;265:299-304. doi: 10.1016/j.atherosclerosis.2017.06.018. Epub 2017 Jun 9.

PMID:
28637586
28.

Xanthomas and atheromas.

Sijbrands EJ.

Atherosclerosis. 2017 Aug;263:315. doi: 10.1016/j.atherosclerosis.2017.06.003. Epub 2017 Jun 6. No abstract available.

29.

Greater preclinical atherosclerosis in treated monogenic familial hypercholesterolemia vs. polygenic hypercholesterolemia.

Sharifi M, Higginson E, Bos S, Gallivan A, Harvey D, Li KW, Abeysekera A, Haddon A, Ashby H, Shipman KE, Cooper JA, Futema M, Roeters van Lennep JE, Sijbrands EJG, Labib M, Nair D, Humphries SE.

Atherosclerosis. 2017 Aug;263:405-411. doi: 10.1016/j.atherosclerosis.2017.05.015. Epub 2017 May 13.

30.

Diet-induced weight loss and markers of endothelial dysfunction and inflammation in treated patients with type 2 diabetes.

Berk KA, Oudshoorn TP, Verhoeven AJM, Mulder MT, Roks AJM, Dik WA, Timman R, Sijbrands EJG.

Clin Nutr ESPEN. 2016 Oct;15:101-106. doi: 10.1016/j.clnesp.2016.06.011. Epub 2016 Jul 25.

PMID:
28531772
31.

Proprotein convertase subtilisin/kexin 9 inhibition in patients with familial hypercholesterolemia: Initial clinical experience.

Galema-Boers AMH, Lenzen MJ, Sijbrands EJ, Roeters van Lennep JE.

J Clin Lipidol. 2017 May - Jun;11(3):674-681. doi: 10.1016/j.jacl.2017.02.014. Epub 2017 Mar 7.

PMID:
28506389
32.

The anti-inflammatory function of high-density lipoprotein in type II diabetes: A systematic review.

Lemmers RFH, van Hoek M, Lieverse AG, Verhoeven AJM, Sijbrands EJG, Mulder MT.

J Clin Lipidol. 2017 May - Jun;11(3):712-724.e5. doi: 10.1016/j.jacl.2017.03.013. Epub 2017 Mar 31. Review.

PMID:
28442299
33.

Novel protein biomarkers associated with coronary artery disease in statin-treated patients with familial hypercholesterolemia.

Bos S, Phillips M, Watts GF, Verhoeven AJM, Sijbrands EJG, Ward NC.

J Clin Lipidol. 2017 May - Jun;11(3):682-693. doi: 10.1016/j.jacl.2017.03.014. Epub 2017 Apr 4.

PMID:
28434814
34.

Oxidized LDL, Gamma-Glutamyltransferase and Adverse Outcomes in Older Adults.

Spoto B, Mattace-Raso F, Sijbrands EJ, D'Arrigo G, Tripepi G, Volpato S, Bandinelli S, Ferrucci L, Zoccali C.

J Am Geriatr Soc. 2017 Apr;65(4):e77-e82. doi: 10.1111/jgs.14566.

35.

Low-density lipoprotein receptor-negative compound heterozygous familial hypercholesterolemia: Two lifetime journeys of lipid-lowering therapy.

Yahya R, Mulder MT, Sijbrands EJ, Williams M, Roeters van Lennep JE.

J Clin Lipidol. 2017 Jan - Feb;11(1):301-305. doi: 10.1016/j.jacl.2017.01.004. Epub 2017 Jan 12.

PMID:
28391901
36.

Effect of diet-induced weight loss on lipoprotein(a) levels in obese individuals with and without type 2 diabetes.

Berk KA, Yahya R, Verhoeven AJM, Touw J, Leijten FP, van Rossum EF, Wester VL, Lips MA, Pijl H, Timman R, Erhart G, Kronenberg F, Roeters van Lennep JE, Sijbrands EJG, Mulder MT.

Diabetologia. 2017 Jun;60(6):989-997. doi: 10.1007/s00125-017-4246-y. Epub 2017 Apr 6.

37.

Low-density lipoprotein receptor mutational analysis in diagnosis of familial hypercholesterolemia.

Bourbon M, Alves AC, Sijbrands EJ.

Curr Opin Lipidol. 2017 Apr;28(2):120-129. doi: 10.1097/MOL.0000000000000404. Review.

PMID:
28169869
38.

Pleiotropic Effect of Human ApoE4 on Cerebral Ceramide and Saturated Fatty Acid Levels.

den Hoedt S, Janssen CIF, Astarita G, Piomelli D, Leijten FPJ, Crivelli SM, Verhoeven AJM, de Vries HE, Walter J, Martinez-Martinez P, Sijbrands EJG, Kiliaan AJ, Mulder MT.

J Alzheimers Dis. 2017;60(3):769-781. doi: 10.3233/JAD-160739.

PMID:
28035926
39.

Serum Levels of Apolipoproteins and Incident Type 2 Diabetes: A Prospective Cohort Study.

Brahimaj A, Ligthart S, Ikram MA, Hofman A, Franco OH, Sijbrands EJ, Kavousi M, Dehghan A.

Diabetes Care. 2017 Mar;40(3):346-351. doi: 10.2337/dc16-1295. Epub 2016 Dec 28.

PMID:
28031419
40.

Carotid artery plaques and intima medial thickness in familial hypercholesteraemic patients on long-term statin therapy: A case control study.

Bos S, Duvekot MH, Ten Kate GR, Verhoeven AJ, Mulder MT, Schinkel AF, Nieman K, Watts GF, Sijbrands EJ, Roeters van Lennep JE.

Atherosclerosis. 2017 Jan;256:62-66. doi: 10.1016/j.atherosclerosis.2016.12.005. Epub 2016 Dec 2.

PMID:
28012444
41.

ADAMTS13 activity as a novel risk factor for incident type 2 diabetes mellitus: a population-based cohort study.

de Vries PS, van Herpt TT, Ligthart S, Hofman A, Ikram MA, van Hoek M, Sijbrands EJ, Franco OH, de Maat MP, Leebeek FW, Dehghan A.

Diabetologia. 2017 Feb;60(2):280-286. doi: 10.1007/s00125-016-4139-5. Epub 2016 Oct 27.

42.

Levels of the soluble LDL receptor-relative LR11 decrease in overweight individuals with type 2 diabetes upon diet-induced weight loss.

Berk KA, Vongpromek R, Jiang M, Schneider WJ, Timman R, Verhoeven AJ, Bujo H, Sijbrands EJ, Mulder MT.

Atherosclerosis. 2016 Nov;254:67-72. doi: 10.1016/j.atherosclerosis.2016.09.066. Epub 2016 Sep 22.

PMID:
27697674
43.

Genomic prediction of coronary heart disease.

Abraham G, Havulinna AS, Bhalala OG, Byars SG, De Livera AM, Yetukuri L, Tikkanen E, Perola M, Schunkert H, Sijbrands EJ, Palotie A, Samani NJ, Salomaa V, Ripatti S, Inouye M.

Eur Heart J. 2016 Nov 14;37(43):3267-3278. Epub 2016 Sep 21.

44.

The Relationship of Metabolic Syndrome Traits with Beta-Cell Function and Insulin Sensitivity by Oral Minimal Model Assessment in South Asian and European Families Residing in the Netherlands.

Geragotou T, Jainandunsing S, Özcan B, de Rooij FW, Kokkinos A, Tentolouris N, Sijbrands EJ.

J Diabetes Res. 2016;2016:9286303. doi: 10.1155/2016/9286303. Epub 2016 Aug 11.

45.

A stable isotope method for in vivo assessment of human insulin synthesis and secretion.

Jainandunsing S, van Miert JNI, Rietveld T, Darcos Wattimena JL, Sijbrands EJG, de Rooij FWM.

Acta Diabetol. 2016 Dec;53(6):935-944. doi: 10.1007/s00592-016-0896-3. Epub 2016 Aug 23.

46.

Predictors of Diet-Induced Weight Loss in Overweight Adults with Type 2 Diabetes.

Berk KA, Mulder MT, Verhoeven AJ, van Wietmarschen H, Boessen R, Pellis LP, van T Spijker A, Timman R, Ozcan B, Sijbrands EJ.

PLoS One. 2016 Aug 5;11(8):e0160774. doi: 10.1371/journal.pone.0160774. eCollection 2016.

47.

Defining severe familial hypercholesterolaemia and the implications for clinical management: a consensus statement from the International Atherosclerosis Society Severe Familial Hypercholesterolemia Panel.

Santos RD, Gidding SS, Hegele RA, Cuchel MA, Barter PJ, Watts GF, Baum SJ, Catapano AL, Chapman MJ, Defesche JC, Folco E, Freiberger T, Genest J, Hovingh GK, Harada-Shiba M, Humphries SE, Jackson AS, Mata P, Moriarty PM, Raal FJ, Al-Rasadi K, Ray KK, Reiner Z, Sijbrands EJ, Yamashita S; International Atherosclerosis Society Severe Familial Hypercholesterolemia Panel.

Lancet Diabetes Endocrinol. 2016 Oct;4(10):850-61. doi: 10.1016/S2213-8587(16)30041-9. Epub 2016 May 27. Review. Erratum in: Lancet Diabetes Endocrinol. 2016 Aug;4(8):e8.

48.

Lomitapide affects HDL composition and function.

Yahya R, Favari E, Calabresi L, Verhoeven AJM, Zimetti F, Adorni MP, Gomaraschi M, Averna M, Cefalù AB, Bernini F, Sijbrands EJG, Mulder MT, Roeters van Lennep JE.

Atherosclerosis. 2016 Aug;251:15-18. doi: 10.1016/j.atherosclerosis.2016.05.005. Epub 2016 May 11.

49.

Familial hypercholesterolaemia: cholesterol efflux and coronary disease.

Versmissen J, Vongpromek R, Yahya R, van der Net JB, van Vark-van der Zee L, Blommesteijn-Touw J, Wattimena D, Rietveld T, Pullinger CR, Christoffersen C, Dahlbäck B, Kane JP, Mulder M, Sijbrands EJ.

Eur J Clin Invest. 2016 Jul;46(7):643-50. doi: 10.1111/eci.12643. Epub 2016 Jun 20.

50.

The clinical value of metabolic syndrome and risks of cardiometabolic events and mortality in the elderly: the Rotterdam study.

van Herpt TT, Dehghan A, van Hoek M, Ikram MA, Hofman A, Sijbrands EJ, Franco OH.

Cardiovasc Diabetol. 2016 Apr 27;15:69. doi: 10.1186/s12933-016-0387-4.

Supplemental Content

Loading ...
Support Center